Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Insignia Financial Ltd ( (AU:IFL) ) has issued an update.
Insignia Financial Ltd has disclosed that it has ceased to be a substantial holder in Botanix Pharmaceuticals Ltd as of 12 March 2026, following a series of on-market trades executed by its investment subsidiaries. The change reflects a net reduction in its voting power in Botanix shares, signaling a move to scale back its exposure to the pharmaceutical company.
Transaction records show an extended period of both purchases and sales by IOOF Investment Services, IOOF Investment Management and MLC Investments between November 2025 and March 2026, culminating in sizeable disposals in early March. The exit from substantial holder status may alter Botanix’s shareholder register composition and slightly reduce the influence of institutional capital from Insignia’s funds over the company’s governance and strategic direction.
The most recent analyst rating on (AU:IFL) stock is a Hold with a A$4.80 price target. To see the full list of analyst forecasts on Insignia Financial Ltd stock, see the AU:IFL Stock Forecast page.
More about Insignia Financial Ltd
Insignia Financial Ltd is an Australian financial services group that operates through subsidiaries including IOOF Investment Services, IOOF Investment Management and MLC Investments. The group provides investment management and related wealth solutions, managing portfolios that include holdings in ASX-listed companies such as Botanix Pharmaceuticals Ltd.
Average Trading Volume: 1,719,635
Technical Sentiment Signal: Buy
Current Market Cap: A$3.12B
Find detailed analytics on IFL stock on TipRanks’ Stock Analysis page.